Q32 Bio
QTTB
79 hedge funds and large institutions have $27.1M invested in Q32 Bio in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 24 reducing their positions, and 15 closing their positions.
500% more call options, than puts
Call options by funds: $96K | Put options by funds: $16K
0.22% less ownership
Funds ownership: 2.32% → 2.1% (-0.22%)
5% less funds holding
Funds holding: 83 → 79 (-4)
27% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 15
29% less capital invested
Capital invested by funds: $38.4M → $27.1M (-$11.3M)
46% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 24
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$129K |
| 2 |
SCM
Springhouse Capital Management
Westport,
Connecticut
|
+$59K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$36.9K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$36.1K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$22.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VVA
Vida Ventures Advisors
Boston,
Massachusetts
|
-$1.12M |
| 2 |
BlackRock
New York
|
-$483K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$384K |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
-$346K |
| 5 |
Millennium Management
New York
|
-$322K |
QTTB Hedge Fund Activity: Q4 2022 in Review
79 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q4 2022, worth a combined $27.1M — down 29% from $38.4M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of QTTB and 11 opened new positions — a net loss of 4 holders — while 24 trimmed existing stakes and 13 added.
The largest buyer was Acadian Asset Management, adding an estimated $129K. The largest seller was Vida Ventures Advisors, exiting entirely with an estimated $1.12M sold.
- 79 institutional investors held Q32 Bio (QTTB) as of Q4 2022, down from 83 in Q3 2022.
- Funds reported $27.1M of Q32 Bio stock for Q4 2022, down 29% quarter-over-quarter.
- 11 funds opened new Q32 Bio positions in Q4 2022 and 15 closed out, a net change of -4 holders.
- The largest Q32 Bio buyer in Q4 2022 was Acadian Asset Management, an estimated $129K added.
- The largest Q32 Bio seller in Q4 2022 was Vida Ventures Advisors, an estimated $1.12M sold.
Based on aggregated 13F filings for Q4 2022.